Targeting metalloenzymes for therapeutic intervention

AY Chen, RN Adamek, BL Dick, CV Credille… - Chemical …, 2018 - ACS Publications
Metalloenzymes are central to a wide range of essential biological activities, including
nucleic acid modification, protein degradation, and many others. The role of metalloenzymes …

Drugs in development for malaria

EA Ashley, AP Phyo - Drugs, 2018 - Springer
The last two decades have seen a surge in antimalarial drug development with product
development partnerships taking a leading role. Resistance of Plasmodium falciparum to the …

Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development

M Schlitzer - ChemMedChem: Chemistry Enabling Drug …, 2007 - Wiley Online Library
Since ancient times, humankind has had to struggle against the persistent onslaught of
pathogenic microorganisms. Nowadays, malaria is still the most important infectious disease …

The apicoplast: now you see it, now you don't

GI McFadden, E Yeh - International journal for parasitology, 2017 - Elsevier
Parasites such as Plasmodium and Toxoplasma possess a vestigial plastid homologous to
the chloroplasts of algae and plants. The plastid (known as the apicoplast; for apicomplexan …

Antimalarial drugs–what is in use and what is in the pipeline

M Schlitzer - Archiv der Pharmazie: An International Journal …, 2008 - Wiley Online Library
Malaria continues to be a potentially fatal threat to almost half of the world's population. In
light of this threat, the armory to fight this disease is rather limited. Resistance against the …

Targeting the methyl erythritol phosphate (MEP) pathway for novel antimalarial, antibacterial and herbicidal drug discovery: inhibition of 1-deoxy-D-xylulose-5 …

N Singh, G Chevé, MA Avery… - Current pharmaceutical …, 2007 - ingentaconnect.com
The 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway for isoprenoid biosynthesis has
come under increased scrutiny as a target for novel antimalarial, antibacterial and herbicidal …

Molecular basis of fosmidomycin's action on the human malaria parasite Plasmodium falciparum

T Umeda, N Tanaka, Y Kusakabe, M Nakanishi… - Scientific Reports, 2011 - nature.com
The human malaria parasite Plasmodium falciparum is responsible for the deaths of more
than a million people each year. Fosmidomycin has been proven to be efficient in the …

Drug repositioning in the treatment of malaria and TB

A Nzila, Z Ma, K Chibale - Future medicinal chemistry, 2011 - Future Science
The emergence and spread of drug resistance in the malaria parasite Plasmodium
falciparum as well as multi-and extremely drug-resistant forms of Mycobacterium …

Biochemistry of the non-mevalonate isoprenoid pathway

T Gräwert, M Groll, F Rohdich, A Bacher… - Cellular and molecular …, 2011 - Springer
The non-mevalonate pathway of isoprenoid (terpenoid) biosynthesis is essential in many
eubacteria including the major human pathogen, Mycobacterium tuberculosis, in …

Plasmodium falciparum apicoplast drugs: targets or off-targets?

CY Botté, F Dubar, GI McFadden, E Maréchal… - Chemical …, 2012 - ACS Publications
The phylum Apicomplexa includes obligate intracellular parasites that cause both benign
and serious diseases. Human infection by Toxoplasma gondii can be asymptomatic but can …